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Baseline Characteristics and Risk Factors of Retinal Vein 
Occlusion: A Study by the Korean RVO Study Group
We investigated the demographic characteristics and risk factors of Korean patients with 
naïve central or branch retinal vein occlusion (CRVO or BRVO). This study enrolled 41 
clinical sites throughout Korea and included 557 consecutive patients with retinal vein 
occlusion (RVO) from May through November 2010. A total of 557 patients with new-
onset RVO participated in this study. Two hundred and three (36.4%) patients were 
diagnosed with CRVO and 354 (63.6%) patients were diagnosed with BRVO. Comparisons 
between the two groups showed that the prevalence of diabetes mellitus was significantly 
higher in CRVO patients and hypertension was significantly higher in BRVO patients 
(P = 0.001 and 0.002, respectively). Poor baseline visual acuity was significantly associated 
with female and old age in BRVO patients (P = 0.002 and 0.013, respectively), whereas the 
wide intraretinal hemorrhage (CRVO, P = 0.029; BRVO, P < 0.001) and the macular 
ischemia (CRVO, P < 0.001; BRVO, P < 0.001) were associated with both groups. The 
study results show the clinical features of RVO in Korean patients. Hypertension is strongly 
associated with BRVO and diabetes mellitus is more strongly associated with CRVO in 
Korean patients with RVO. As the first nationwide study performed by the Korean Retinal 
Society, the results of this study can be applied to future studies on RVO. 
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INTRODUCTION
Retinal vein occlusion (RVO) is a major retinal vascular disor-
der that causes sight-threatening conditions in older adults. Sec-
ondary macular edema usually results in decreased visual acu-
ity due to either central retinal vein occlusion (CRVO) or branch 
retinal vein occlusion (BRVO) (1). Previously reported major 
epidemiologic studies have described the prevalence, systemic 
risk factors, and clinical course of RVO, but most of these stud-
ies were performed in white populations (2-6). Only limited 
studies on RVO in Asian populations have been performed (7-
9). In addition, there are no large-scale studies on the incidence, 
risk factors, or clinical patterns of RVO in Korean populations. 
 The purpose of this study was to examine the demographic 
characteristics and risk factors of naïve RVO patients who visit-
ed tertiary care centers in Korea. Because Korea is a racially ho-
mogenous nation, the study results can provide additional in-
formation about the clinical features of RVO in other northeast 
Asian countries. 
MATERIALS AND METHODS
This multicenter, cross-sectional study was performed as a na-
tionwide survey in 2010. The survey included a detailed inter-
view regarding RVO-related risk factors. In addition, the system-
ic and ocular findings in each patient were confirmed by retinal 
specialists.
Study population
All 557 consecutive new cases of RVO that presented at each in-
stitute were included in this study. For each patient, complete 
physical and ocular examinations were performed, including 
an interview regarding past medical history. To confirm RVO, 
an ocular examination was performed on all patients that in-
cluded fundus photography, fluorescein angiography, and op-
tical coherence tomography (OCT). 
Inclusion and exclusion criteria
All patients included in this study were diagnosed with new-on-
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set RVO (≤ 6 months). Patients with diabetic retinopathy (ex-
cept mild nonproliferative diabetic retinopathy), RVO due to 
other causes (e.g., known uveitis or vasculitis), RVO accompa-
nied by arterial occlusion or ocular ischemic syndrome, or a 
prior history of intraocular injection, laser treatment, or vitrec-
tomy for RVO were excluded from the study population. 
Evaluation of the systemic risk factors 
Detailed data on patient demographics, past medical histories, 
and ocular symptoms were collected. Each patient’s complete 
systemic medical history related to RVO was examined for indi-
cations of hypertension, diabetes mellitus (DM), heart disease, 
cerebrovascular accidents, renal disease, and hyperlipidemia. 
Lifestyle factors, such as smoking habits and alcohol consump-
tion, were determined from the initial interview. Resting blood 
pressure was measured using standard protocols. In addition, 
24-hr blood pressure monitoring was performed, if needed, for 
the diagnosis of hypertension. To confirm other systemic dis-
eases, some patients underwent laboratory testing that includ-
ed a complete blood count, electrolyte and chemical batteries, 
lipid panel, determination of fasting blood sugar, postprandial 
blood sugar test, and hemophilia testing. 
Ocular examinations 
Snellen best-corrected visual acuity (BCVA), refractive error, and 
intraocular pressure were determined and recorded. A detailed 
anterior segment examination was carried out to determine if 
neovascularization of the iris had occurred. After dilation of the 
pupil, the lens status was determined and a fundus examination 
was performed. The findings of the fundus examination were 
recorded in terms of the type of RVO (CRVO or BRVO), presence 
of any optic disc abnormalities, macular edema, neovascular-
ization at the disc or elsewhere, extent of retinal hemorrhage, 
and other abnormal findings such as vitreous hemorrhage. The 
patient’s history of ocular surgery was also determined, includ-
ing cataract surgery, vitrectomy, and glaucoma surgery. 
 Baseline fundus photography, fundus fluorescein angiogra-
phy, and OCT were performed on all patients. Each scan set was 
independently graded by two different readers. In cases of dis-
agreement, the senior reader made a unilateral decision regard-
ing unresolved data. Using imaging data, the scan quality was 
first evaluated. Then, using fundus photography, the type of 
RVO, location of RVO, and abnormalities in the optic disc area 
and macular area were reassessed. Using early- and peak-phase 
fluorescein angiography, abnormalities in the optic disc area 
(e.g., leakage, presence of collaterals, and neovascularization), 
the presence of macular ischemia (e.g., foveal avascular zone 
disruption, leakage, and intraretinal cystoid spaces), the extent 
of capillary nonperfusion, and the presence of neovasculariza-
tion in the parafoveal area were examined. In this study, eyes 
with hemiretinal vein occlusion are regarded as eyes with CRVO 
and assigned to the CRVO group. Using the horizontal and ver-
tical OCT images, the central macular thickness and abnormal-
ities of the vitreomacular interface, including epiretinal mem-
brane, macular edema, photoreceptor inner segment/outer seg-
ment disruption, intraretinal cyst, and the presence of subreti-
nal fluid, were assessed. Differences in central macular thick-
ness, depending on the OCT machine used, were corrected ac-
cording to an established reference (10). 
Statistical analysis
Differences in the baseline continuous variables between the 
patients with CRVO and BRVO were evaluated using the t test. 
The Pearson chi-square test and Fisher exact test were used to 
test for differences in the baseline categorical variables between 
participants with CRVO and BRVO. The Pearson correlation co-
efficient was used to measure the linear association between 
baseline logMAR visual acuity and the central thickness deter-
mined using OCT. Univariate analysis was performed to deter-
mine the association between the baseline variables and Snel-
len visual acuity. The patients were divided into 3 groups accord-
ing to baseline Snellen visual acuity: ≤ 0.2, 0.2-0.5, and > 0.5. 
In patients with RVO, one-way analysis of variance (ANOVA) 
was used to identify associations between baseline BCVA and 
the continuous variables, and the Pearson chi-square test was 
used to identify the association between baseline BCVA and the 
categorical variables.  
 After identifying the significant factors using univariate anal-
ysis, multiple linear regression models were used to describe 
the association between variables and baseline logMAR visual 
acuity. Standardized beta coefficients were used to compare 
changes in baseline BCVA that were associated with the inde-
pendent variables that were expressed in incomparable units of 
measurement. SPSS (version 18.0; SPSS Inc., Chicago, IL, USA) 
was used to conduct all of the statistical analyses, and P < 0.05 
was considered statistically significant. 
Ethics statement 
This study followed the principles of the Declaration of Helsinki 
and was approved by the institutional review board of Asan Med-
ical Center, Seoul, Korea (IRB No. # 2010-0567). Informed con-
sent was waived by the board.
RESULTS
Baseline data were collected from 557 consecutive RVO patients 
from 41 clinical sites throughout Korea during the 7-month pe-
riod from May through November 2010. Baseline demographic 
data on the study population are shown in Table 1. This study 
included data on 203 patients with CRVO (36.4%) and 354 pa-
tients with BRVO (63.6%). The CRVO population contained sim-
ilar proportions of men and women, however the number of 
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female patients was higher in the BRVO population. The mean 
ages were similar in both groups (59.8 yr [range: 16-89]) for CRVO 
and 58.2 yr [range: 31-97] for BRVO). Also, there were no differ-
ences in terms of the age distributions. 
 The baseline systemic and ocular conditions of the study pop-
ulation are shown in Table 2. The prevalence of DM and hyper-
tension was generally high in both groups. However, the preva-
lence of hypertension at baseline was higher in the BRVO group 
(48.2%) than the CRVO group (34.7%, P = 0.002). In terms of DM, 
CRVO patients (20.2%) demonstrated a higher prevalence at 
baseline than BRVO patients (9.9%, P = 0.001). The mean rest-
ing systolic and diastolic blood pressures were also higher in 
BRVO patients (P = 0.003 and 0.008, respectively). There was no 
statistically significant difference between the 2 groups in terms 
of the incidence of cerebrovascular accident (CVA), renal dis-
ease, ocular surgery, or smoking. 
 In terms of ocular symptoms, even though the CRVO patients 
tended to visit a hospital a few days earlier than the BRVO group, 
there was no difference between the 2 groups in terms of the 
reported duration of symptoms at the initial consultation (P =  
0.063).
 BCVA demonstrated a significant difference between 2 groups. 
The percentage of CRVO patients with Snellen BCVA < 0.2 was 
higher and the mean logMAR BCVA of the CRVO patients was 
also significantly worse (P = 0.025 and 0.002, respectively). The 
number of CRVO patients with a Snellen BCVA ≤ 0.2 was 91 
(44.8%). The distribution of visual acuity was significantly dif-
ferent from that of the BRVO patients, which consisted of 118 
patients with a Snellen BCVA ≤ 0.2 (35.1%). 
 Also, the baseline OCT-measured center macular thickness 
was higher in the CRVO patients. The mean OCT-measured 
center point thickness was 499.65 µm in CRVO patients and 
444.38 µm in BRVO patients (P = 0.002). In terms of wide intra-
retinal hemorrhage in the central area, BRVO patients demon-
strated a higher percentage of occurrence (80.4%) than CRVO 
patients (69.3%, P = 0.005). However, more CRVO patients pre-
sented with a wide nonperfusion area on angiography (P =  
Table 1. Baseline demographic features of the enrolled patients
Parameters
No. (%) of patients
P *
CRVO BRVO Total
Number of patients 203 (36.4%) 354 (63.6%) 557 (100%)
Male (%):Female (%) 107 (52.7):96 (47.3) 146 (41.2):208 (58.8) 253 (45.4):304 (54.6) 0.009
Mean age (yr) 59.8 58.2 58.8 0.132
Age range, No. (%)
   0-40
   40-49
   50-59
   60-69
   70-79
   80+
   Total
 
 11 (5.4)
   31 (15.3)
   57 (28.1)
   55 (27.1)
   41 (20.2)
   8 (3.9)
203 (100)
 
  12 (3.4)
   60 (16.9)
 125 (35.3)
 104 (29.4)
   45 (12.7)
   8 (2.3)
354 (100)
 
 23 (4.1)
   91 (16.3)
 182 (32.7)
 159 (28.5)
   86 (15.4)
 16 (2.9)
557 (100)
0.082
*Comparison between CRVO and BRVO patients. CRVO, central retinal vein occlusion; BRVO, branch retinal vein occlusion.
Table 2. Baseline systemic and ocular conditions of the enrolled patients
Medical conditions
No. (%) of patients
P
CRVO BRVO
Systemic conditions
   DM    41 (20.2%) 35 (9.9%) 0.001
   Hypertension    70 (34.7%) 170 (48.2%) 0.002
   CVA    6 (3.0%) 11 (3.1%) 0.947
   Renal disease    7 (3.5%)   8 (2.3%) 0.398
   Mean BP 
      Systolic BP 
      Diastolic BP 
  
132.3 
  79.7
  
137.1 
  82.4
  
0.003
0.008
   Smoking 
      Current smoker 
      Ex-smoker 
      Nonsmoker 
 
   28 (15.0%)
   31 (16.6%)
 128 (68.4%)
 
  45 (13.4%)
  49 (14.6%)
242 (72.0%)
0.689
   Previous cataract surgery    21 (10.3%) 21 (5.9%) 0.058
   Previous vitreoretinal surgery 0 (0%)   2 (0.6%) 0.284
   Glaucoma surgery    1 (0.5%)   1 (0.3%) 0.690
   Others    9 (4.4%) 13 (3.7%) 0.657
Ocular conditions
   Duration of symptoms (days)   28.6   35.2 0.063
   Visual acuity 
      Snellen 
        ≤ 0.2 
         0.2-0.5 
        > 0.5 
         Mean logMAR
  
 
   91 (44.8%)
   53 (28.1%)
   59 (31.8%)
      0.68
  
 
118 (35.1%)
108 (30.3%)
128 (34.6%)
      0.52
  
0.025
 
 
 
0.002
      Refractive error
         Hyperopia
         Emmetropia
         Myopia
 
 118 (58.1%)
 15 (7.4%)
   70 (34.5%)
 
201 (56.8%)
33 (9.3%)
120 (33.9%)
0.736
  
  
0.116
      Mean IOP (mmHg)   14.5   14.0
   OCT-measured central macular 
      thickness
499.65 µm 444.38 µm 0.002
   Intraretinal cyst on OCT  144 (72.0%) 246 (71.3%) 0.862
   Intraretinal hemorrhage 
     ≥ 5 DA 
     < 5 DA 
 
 140 (69.3%)
   62 (30.7%)
 
279 (80.4%)
  68 (19.6%)
0.003
   Nonperfusion
     ≥ 5 DA 
     < 5 DA 
 
192 (100%)
0 (0%)
 
317 (96.0%)
13 (4.0%)
0.005
CRVO, central retinal vein occlusion; BRVO, branch retinal vein occlusion; DM, diabe-
tes mellitus; CVA, cerebrovascular accident; BP, blood pressure; IOP, intraocular pres-
sure; OCT, optical coherence tomography; DA, disc area.
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0.005). 
 The relationship between BCVA at baseline and the other de-
mographic and ocular characteristics was analyzed using uni-
variate analysis and multiple regression analysis (Table 3 and 
Table 4). Using univariate analysis, old age, female sex, wide area 
of intraretinal hemorrhage, and the presence of macular isch-
emia on fluorescein angiography were found to be significant 
factors associated with poor BCVA in BRVO patients. For CRVO 
Table 3. Univariate analysis of the factors associated with baseline BCVA
Variables
CRVO
P
BRVO
PSnellen VA Snellen VA
≤ 0.2 (%) 0.2-0.5 (%) > 0.5 (%) ≤ 0.2 (%) 0.2-0.5 (%) > 0.5 (%)
Systemic conditions
   Age 
      Mean (yr)
      10-yr interval
     < 40
      40-50
      50-60
      60-70
      70-80
     > 80
 
62.4
 
2 (18.1)
16 (51.6)
17 (29.8)
28 (50.9)
24 (58.5)
4 (50.0)
 
61.0
 
1 (9.0)
5 (16.1)
20 (35.1)
17 (30.9)
7 (17.0)
3 (37.5)
 
54.7
 
8 (72.7)
10 (32.3)
20 (35.1)
10 (18.2)
10 (24.4)
1 (12.5)
 
0.001
0.006
 
60.8
 
3 (25.0)
14 (23.3)
38 (30.4)
41 (39.4)
20 (44.4)
2 (25.0)
 
57.8
 
2 (16.7)
24 (40.0)
38 (30.4)
23 (22.1)
17 (37.8)
4 (50.0)
 
56.0
 
7 (28.3)
22 (36.7)
49 (39.2)
40 (38.0)
8 (17.8)
2 (25.0)
 
0.002
0.045
   Sex (male)
      Male (n)
      Female (n)
 
52 (46.7)
39 (40.6)
 
24 (21.7)
29 (30.2)
 
31 (31.5)
28 (29.2)
0.389  
39 (26.7)
79 (38.0)
 
40 (27.4)
68 (32.7)
 
67 (45.9)
61 (29.3)
0.005
   DM 
      Yes (n)
      No (n)
 
22 (52.4)
69 (42.6)
 
13 (31.7)
40 (24.7)
 
6 (14.6)
53 (32.7)
0.075  
11 (31.4)
107 (33.5)
 
10 (28.6)
98 (30.7)
 
14 (40.0)
114 ( 35.7)
0.883
   Hypertension 
      Yes (n)
      No (n)
 
34 (48.6)
56 (42.4)
 
19 (10.3)
34 (25.8)
 
17 (24.3)
42 (31.8)
0.519  
52 (30.6)
65 (35.5)
 
60 (35.3)
48 (26.2)
 
58 (34.1)
70 (38.3)
0.180
   CVA 
      Yes (n)
      No (n)
 
4 (66.7)
83 (43.0)
 
0 (0)
53 (27.5)
 
2 (33.3)
57 (29.5)
0.298  
2 (18.2)
116 (33.9)
 
4 (36.4)
103 (30.1)
 
5 (45.5)
123 (36.0)
0.551
   Renal disease
      Yes (n)
      No (n)
 
4 (57.1)
84 (43.5)
 
2 (28.6)
51 (26.4)
 
1 (14.3)
58 (30.1)
0.649  
3 (37.5)
114 (33.2)
 
2 (25.0)
104 (30.3)
 
3 (37.5)
125 (36.4)
0.943
   Smoking 
      Yes (n)
      Ex-smoker (n)
      No (n)
 
13 (46.4)
13 (41.9)
56 (43.8)
 
8 (28.6)
8 (25.8)
31 (24.2)
 
7 (25.0)
10 (32.3)
41 (32.0)
0.959  
14 (31.1)
11 (22.4)  
83 (34.3)
 
12 (26.7)
16 (32.7)
78 (32.2)
 
19 (16.2)
22 (44.9)
81 (33.5)
0.385
   BP 
      Mean Systolic BP (mmHg)
      Mean Diastolic BP (mmHg)
  
136.0
  81.1
 
132.6
  79.2
 
126.5
  78.1
 
0.007
0.267
 
137.0
  81.0
 
138.3
  83.8
 
136.3
  82.6
 
0.714
0.233
Ocular conditions
   Disease onset 
      Mean (days)
 
78 (44.3)
 
48 (27.3)
 
50 (28.4)
 
0.386
 
95 (34.9)
 
87 (32.0)
 
90 (33.1)
 
0.418
   Refractive error  
      Yes (n)
      No (n))
 
66 (42.3)
10 (66.7)
 
43 (27.6)
2 (13.3)
 
47 (30.1)
3 (20.0)
0.186   
93 (32.7)
5 (26.3)
 
82 (28.9)
10 (52.6)
 
109 (38.4)
4 (21.1)
0.083
   IOP (mmHg)   14.7   14.4   14.4 0.886   13.7   14.4   14.0 0.309
   Glaucoma 
      Yes (n)
      No (n)
 
5 (71.4)
85 (43.6)
 
1 (14.3)
52 (26.7)
 
1 (14.3)
58 (29.7)
0.346  
1 (25.0)
117 (33.4)
 
1 (25.0)
107 (30.6)
 
2 (50.0)
126 (36.0)
0.844
   Intraretinal hemorrhage (≥ 5 DA)
      Yes (n)
      No (n)
 
41 (66.1)
49 (35.0)
 
8 (12.9)
45 (32.1)
 
13 (21.0)
46 (32.9)
< 0.001
35 (51.5)
81 (29.0)
 
24 (35.3)
80 (28.7)
 
9 (13.2)
118 (42.3)
< 0.001
   Nonperfusion area (≥ 5 DA)
      Yes (n)
      No (n)
 
86 (44.8)
0 (0)
 
49 (25.5)
0 (0)
 
57 (29.7)
0 (0)
  
106 (33.4)
4 (30.8)
 
93 (29.3)
6 (46.2)
 
118 (37.2)
3 (23.1)
0.390
   Macular ischemia 
      Yes (n)
      No (n)
 
42 (65.6)
40 (32.0)
 
14 (21.9)
34 (27.4)
 
8 (12.5)
50 (40.3)
< 0.001  
56 (47.9)
53 (26.4)
 
39 (33.3)
59 (29.4)
 
22 (18.8)
89 (44.2)
< 0.001
BCVA, best-corrected visual acuity; CRVO, central retinal vein occlusion; BRVO, branch retinal vein occlusion; VA, visual acuity; DM, diabetes mellitus; CVA, cerebrovascular ac-
cident; BP, blood pressure; IOP, intraocular pressure; DA, disc area; SE, spherical equivalent.
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patients, old age, high systolic blood pressure, wide area of intra-
retinal hemorrhage, and the presence of macular ischemia on 
fluorescein angiography were also significant factors. On multi-
ple regression analysis, the significant factors associated with 
the development of poor baseline visual acuity were female sex 
and old age for the BRVO patients, whereas a wide area of intra-
retinal hemorrhage and the presence of macular ischemia were 
significant factor for both groups. In both groups, high OCT-mea-
sured central macular thickness was a significant factor associ-
ated with a low initial BCVA. However, the correlation coeffi-
cients were relatively low (CRVO = 0.396; BRVO = 0.390; Fig. 1). 
DISCUSSION
This study was performed as a nationwide study in Korea. For-
ty-one clinical sites throughout Korea participated. Comparing 
the national distribution of the participating clinical sites with 
that of the general population of Korea, the number of partici-
pating clinical sites that were located in Seoul is relatively high 
(Table 5) (11, 12). However, considering the national distribu-
tion of upper-level general hospitals (officially designated as ter-
tiary hospital by the Ministry of Health and Welfare of Korea), 
the number of upper-level general hospitals and participating 
clinical sites in Seoul are similar (17 [38.6%] and 18 [43.9%]), re-
spectively). Furthermore, the distribution of participating clini-
cal sites in other areas also shows a similar pattern with that of 
the upper-level general hospitals. In addition, in the case of the 
diagnosis of a relatively serious disease, such as RVO, many Ko-
reans tend to visit general hospitals in major cities, including 
Seoul, rather than staying at local primary healthcare clinics. 
Considering these facts, the characteristics of the consecutive 
new-onset RVO patients who were enrolled in this study might 
be representative of the nature of Korean RVO patients, includ-
Table 4. Multiple regression analysis of the baseline BCVA and clinical features
Systemic conditions
CRVO BRVO
Beta P Beta P
Sex 0.023 0.744 0.178 0.002
Age (yr) 0.123 0.088 0.146 0.013
Blood pressure 
   Mean systolic BP (mmHg)
   Mean diastolic BP (mmHg)
 
0.145
0.023
 
0.116
0.802
 
0.042
-0.095
 
0.613
0.255
Intraretinal hemorrhage
  ≥ 5 DA 
 
0.152
 
0.029
 
0.201
 
< 0.001
Macular ischemia 
   Yes 
 
-0.389
 
< 0.001
 
-0.200
 
< 0.001
BCVA, best-corrected visual acuity; CRVO, central retinal vein occlusion; BRVO, branch 
retinal vein occlusion; BP, blood pressure; DA, disc area.
Table 5. Comparison of the general population, number of upper-level general hospitals, and participating clinical sites in Korea
Area General population %
No. of upper-level 
general hospitals
%
No. of participating 
clinical sites
%
Seoul 9,762,546 20.8 17 38.6 18 43.9
Gyeonggi-do 12,858,686 22.0 6 13.6 9 22.0
Chungchung-do 4,771,840 10.1 5 11.4 2 5.7
Gangwon-do 1,460,770 3.1 2 4.5 1 4.9
Jeolla-do 5,007,697 10.6 4 9.1 3 7.3
Kyungsang-do 11,604,275 24.7 10 22.7 8 19.5
Total 45,465,814 91 44 100 41 100
Fig. 1. Scatter plot of baseline OCT-measured central macular thickness and BCVA in (A) CRVO (correlation coefficient = 0.396, P < 0.001) and (B) BRVO patients (correlation 
coefficient = 0.390, P < 0.001). BCVA, best-corrected visual acuity; OCT, optical coherence tomography; CRVO, central retinal vein occlusion; BRVO, branch retinal vein occlusion.
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ing the incidence of RVO and the distribution ratio of BRVO: 
CRVO. 
 The results of the current study demonstrate the association 
between both types of RVO, systemic hypertension, and DM. 
According to recent reports, the prevalence of systemic hyper-
tension and diabetes in adults > 30 yr old in Korea are 26.9% 
and 9.7%, respectively (13). Compared with these data, the prev-
alences of both diseases are high in this study group. These find-
ings have already been noted in previous studies on CRVO and 
BRVO (14-19). In this study, the prevalence of hypertension in 
BRVO patients (48.2%) was significantly higher compared with 
the prevalence of hypertension in CRVO patients (34.7%; P =  
0.002). Also, the mean resting blood pressure (both systolic and 
diastolic) was significantly higher in BRVO patients (BRVO, 137.1/ 
82.4 mmHg; CRVO, 132.3/79.7 mmHg). This may suggest that 
hypertension is a more important risk factor for the develop-
ment of BRVO than CRVO in Korean RVO patients. A previously 
reported large-scale study also noted that systemic hyperten-
sion was a greater risk factor for the development of BRVO (270 
patients) than CRVO (258 patients), demonstrating a borderline 
level of statistical significance (P = 0.09) (20). 
 This result may reflect differences in the pathogeneses of BRVO 
and CRVO. The well-known important factors that demonstrate 
a relationship between BRVO and hypertension are degenera-
tive changes in the vessel wall and compression of the vein at 
the arteriovenous crossing site. A number of studies have also 
shown histological changes in vessel walls. Seitz (21) suggests 
that compression of the overlaying artery causes trophic changes 
to the venous endothelium and intima media that are the root 
of BRVO pathogenesis. In addition, Frangieh et al. (22) reported 
that 90% of patients showed evidence of intima-medial layer 
hypertrophy and intravenous thrombosis. Anatomical features 
can also be related to the development of hypertension, such as 
sharing a common adventitial sheath and a relatively anteriorly 
positioned retinal artery. 
 The prevalence of DM was significantly higher in CRVO pa-
tients (CRVO, 20.2%; BRVO, 9.9%; P = 0.001). The cumulative ev-
idence gathered from previous studies supports our data. How-
ever, treatment of DM is associated with a higher risk of develop-
ing CRVO than the risk factors associated with CRVO and BRVO 
(18, 20). Also, Suzuki et al. (23) noted that multiple inflammato-
ry cytokines and neurotrophic factors (such as vascular endo-
thelial growth factor [VEGF] and anti-inflammatory cytokines 
including interleukin [IL]-10 and IL-13) may be involved in the 
common pathogenic mechanisms of CRVO and diabetic reti-
nopathy. The associations between the cardiovascular risk fac-
tors of Korean RVO patients appear to be similar to those of other 
population-based studies. Hypertension may be a more impor-
tant contributing factor to the development of BRVO, and DM 
may be related to the development of CRVO. 
 The current study analyzed the relationship between base-
line BCVA and demographic features, ocular findings, and sev-
eral other parameters determined by ocular examinations. This 
study shows that female sex was one of the demographic factors 
associated with low baseline BCVA in BRVO group. To identify 
the possible reason, we compared the age distributions of the 
male and female patients in the BRVO group. The proportion of 
elderly persons (> 60 yr of age) in the female subgroup was high-
er compared with that of the male subgroup (50.2% vs 37.2%, 
respectively). Old age itself may act as causative factor for low 
visual acuity, as it is also associated with senile cataracts, age-
related macular degeneration, and other degenerative condi-
tions. Also, the baseline demographic data of this study show 
that the proportion of female patients in the BRVO group was 
significantly higher compared with that of the CRVO group. These 
facts might reflect the difference in the incidence of BRVO be-
tween males and females, especially in the elderly Korean pop-
ulation. 
 In terms of the findings on the ocular examinations, wide (> 5 
disc areas) areas of intraretinal hemorrhage and the presence 
of macular ischemia in both groups were significant factors as-
sociated with a low baseline BCVA. These findings indicate that 
a large amount of intraretinal hemorrhage and severe ischemic 
retinal damage follow vascular occlusion and are the main causes 
of the loss of visual acuity. 
 In addition, this study may provide data on the natural cours-
es of both ischemic and nonischemic CRVO. Even though we 
did not define ischemic CRVO, such as areas ≥ 10 disc areas of 
retinal capillary nonperfusion on fluorescein angiography, we 
can classify CRVO patients according to their initial ocular con-
dition and examination results. Large areas of capillary nonper-
fusion (≥ 5 disc areas), severe venous dilatation and tortuosity, 
retinal hemorrhage, macular edema, cotton wool spots, and se-
verely decreased initial visual acuity could be the criteria for the 
diagnosis of ischemic and nonischemic CRVO. At the end of 
data collection and analysis, not only were the natural courses 
of ischemic and nonischemic CRVO described, but so were the 
contributing factors for the conversion from nonischemic to 
ischemic CRVO. 
 Similar to other studies, the OCT-measured macular and fo-
veal thickness did not show a strong correlation with visual acu-
ity in either group (CRVO, 0.396; BRVO, 0.390; Fig. 1). These 
findings also support the notion that OCT-measured macular 
thickness does not exactly represent visual acuity. A previously 
published study explained the weak correlation between OCT-
measured macular thickness, macular ischemia, photoreceptor 
damage, and the accumulation of subfoveal hard exudates, not 
only in RVO but also other retinal disease such as diabetic reti-
nopathy and age-related macular degeneration (24-29). 
 The limitations of our study include the nature of its cross-
sectional design. Causality cannot be inferred from the results. 
Second, this study was performed as a survey, not a clinical trial. 
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This means that there was no strict protocol for acquiring data. 
Because of that, various kinds of machines (e.g., fundus camer-
as and OCT machines) and scan methods were used. This fact 
makes it impossible to apply a standard protocol to each case. 
However, all of the imaging data were interpreted by highly 
skilled retinal specialists who were blind to the clinical charac-
teristics using a common grading protocol. Also, poor-quality 
images, such as those with an off-centered placement or poor 
focus, were excluded from the data analysis. These efforts may 
make up for the weak points of this study. 
 In conclusion, the results of this study show that hyperten-
sion is strongly associated with BRVO and DM is more strongly 
associated with CRVO in Korean patients with RVO. Further-
more, severe intraretinal hemorrhage and macular ischemia 
were significantly associated with poor baseline visual acuity in 
both patients with CRVO and BRVO. The findings obtained at 
the initial visit and the ocular imaging data obtained at baseline 
give us additional information related to visual acuity. This is the 
first nationwide cross-sectional study performed by the Korean 
Retinal Society that describes the clinical features of RVO. The 
results of this study can be applied to future studies on RVO. 
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